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p-value= 0.33); however the likelihood of receiving BCS was lower in non-SNP DEs 
than in both non-DEs (OR: 0.81, p-value< 0.0001) and D-SNPs (OR: 0.76, p-value= 
0.0002). CONCLUSIONS: The probability of receiving BCS was lower in dual members 
not in a D-SNP plan than in duals enrolled in D-SNP plans and non-DE populations. 
There was no significant difference in the probability between D-SNP and non-DE 
populations. The findings indicate that SNP plans produce better results in dual 
members compared to duals not in a SNP plan. This provides evidence of the value 
of SNP plans in achieving better outcomes for the vulnerable DE MA population.
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OBJECTIVES: Asthma holds considerable risk for developing lung cancer. It can 
be assumed that asthma has an effect on hospitalizations and healthcare costs 
accrued by lung cancer patients. This study looks at differences in patient char-
acteristics, healthcare utilizations and costs between lung cancer patients with 
asthma and without asthma. METHODS: The study used 2010 Seer-Medicare reg-
istry and hospitalization data for cancer sites lung, bronchus and not otherwise 
specified lung cancer to look at patient characteristics and measures of health 
service utilizations and costs. Two patient groups were formed based on having any 
or no asthma diagnosis during hospitalization. Descriptive statistics like frequency, 
percentage, mean and standard deviation were used to characterize differences in 
patient demographics, cancer histology, service utilization and costs between the 
two groups. RESULTS: In the prevalence sample of 14371 cases, 508 patients had a 
diagnosis of asthma. Patient characteristics like gender female (66.34% vs 49.34%), 
race African American (18.11% vs 10.86%), residence in big metropolis (56.69% vs 
51.40%) and histology squamous cell carcinoma (24.41% vs 22.31%) showed differ-
ences in presence of asthma in the population. Asthmatics (mean: 7.29 days; SD: 
13.70) had lower mean length of stay when compared to non-asthmatics (mean: 
8.56 days; SD: 16.73). Asthmatics had more intermediate inpatient intensive care 
use (54.55% vs 52.18%) and had more pharmacy costs (mean: $4853.53; SD: 11038.30 
vs mean: $4167.20; SD: 6132.22) and outpatient costs (mean: $11.59; SD: 237.65 vs 
mean: $5.26; SD: 90.40) when compared to non-asthmatics. CONCLUSIONS: There 
are subtle differences in patient characteristics, healthcare utilization and costs 
between lung cancer with asthma and without asthma. Intuitively, utilizations and 
costs should be more abundant in asthmatics. However, our study suggests that this 
variation may not be marked across all utilization and cost measures.
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OBJECTIVES: Research indicates that waste and inefficiency consumes 10% to 30% 
of health care spending, but exactly what health care interventions are contributing 
the most to this misallocation is poorly understood. Some “low-value” interventions 
that offer relatively low or no additional health benefits for their costs have been 
identified in comparative effectiveness and cost-effectiveness literature. Our study 
aims to quantify the healthcare resources and expenditures spent on low-value 
interventions in Massachusetts (MA) in an effort to better understand and allocate 
healthcare spending. For this abstract we present results for the use of arthro-
scopic surgery for knee osteoarthritis. METHODS: We identified a list of low-value 
services based on published literature, which included arthroscopic debridement/
chondroplasty for knee osteoarthritis (procedure codes: 29877, 29879, and G0289). We 
used the 2012 MA All Payer Claims Database (APCD) to examine the proportion and 
characteristics of the individuals who received these services, and to calculate the 
state’s associated annual healthcare expenditure. The APCD included medical and 
pharmacy claims from all commercial payers and certain public programs (Medicare 
Part C only and Medicaid), including patient out-of-pocket payments. RESULTS: 
From our study population (N= 6,549,289), a total of 8,488 individuals were identi-
fied as receiving arthroscopic knee surgery in 2012. Of these patients 52.5% were 
aged < 50 years, and 52% were female. Total state healthcare spending associated 
with this procedure in 2012 was $8.7 million, 95% of which were spent by private 
payers. Most (64%) of the resources were utilized in the outpatient setting, followed 
by other sites of service (non-inpatient and non-outpatient, such as swing-bed and 
ambulatory surgical center) (27%). CONCLUSIONS: Quantifying the resources spent 
on low value interventions can help decision makers gain insight on the potential 
healthcare savings that could be accrued if healthcare resources were reallocated 
away from these interventions.
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OBJECTIVES: Visual impairment (VI) is related to poor health outcomes such as dif-
ficulty with everyday activities, falls, and fracture. However, it is unclear whether VI 
is associated with increased hospitalization. The objective of the study is to deter-
mine whether higher levels of VI are associated with increased rates of hospitaliza-
tion. METHODS: We used a retrospective cohort study design. The Medicare Current 
Beneficiary Survey (MCBS) data covering the 2005 to 2010 time period were used to 
identify community-dwelling beneficiaries, 65 years old and older who provided 
population, while also revealing the potential limitations of the model in response 
to a sudden influx of heavy utilizers.
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OBJECTIVES: In preparation of the self-administered HPV test in Argentina, the 
goal of this paper is to document the Federal Program for the Prevention of Cervix-
Uterus Cancer (PNPCCU) operation at the first level of care and its upstream 
linkages at the secondary and tertiary levels, identifying process and outputs indi-
cators. METHODS: The project designed and implemented a series of question-
naires distributed to the local Ministry of Health, each one of its four Programmatic 
Regions, a sample of 111 health care centers (CAPs), cito/colposcopy labs and gyne-
cology services in charge of treating cancer. Information about procedures to take 
Papanoicolau samples, submit them to labs, receive results and communicate them 
to patients was collected. Descriptive statistics, robust MLS and logistics regressions 
were used to analyze the dataset. RESULTS: The outreach activities through sani-
tary agents have a potential deficit in capturing eligible women (35-60 years old). 
Although 63,6-70% of CAPs reports systematic mechanisms to submit Pap samples 
to labs according to norm, strong idiosyncratic-informal criteria prevail, with mix 
effects on efficacy in outputs. A significant proportion of centers are not able to meet 
PNPCCU recommendation of a maximum four-week time-span between samples is 
taken at CAPs and results reach patients. Time gaps (one-to-four weeks) are found 
across regions between the time abnormal results are identified and treatments are 
initiated. Besides, coverage of such cases is completely addressed and dropout rates 
are nil. CONCLUSIONS: The econometric analysis provides insights about the poor 
influence of context variables on process indicators (Paps performed, and number of 
weeks since sample is performed and results reach the patient). Also, the analysis 
identifies that the reduction of idle-times in identification and communication as 
well the improvement of equitable results are under the span of action of CAPs and 
the coordination of the primary level’s health care network.
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OBJECTIVES: Even though stillbirths audit improves healthcare quality, it is 
invisible in global policy prioritization (UNICEF, 2009) as its not counted in local 
data collection. This study assessed deployment of novel stillbirth audit tool in 
Ghana. METHODS: A standardized Stillbirth audit tool and protocol developed by 
the Regional audit task group using the Vanotoo design, Ghana Maternal death 
Notification form and Perinatal Society of Australia and New Zealand perinatal 
death guidelines. District and audit committees were formed and trained. The tool 
was deployed from January 2014 in the Greater Accra Region. Census of all audited 
stillbirths in 2014 was made. Data on total stillbirth and deliveries abstracted from 
District Health Information Management System 2. Data entered and analyzed in 
Epi info 7. RESULTS: Total of 109,187 deliveries with 2087 stillbirths (19.1 stillbirths 
per 1000 deliveries) was documented. Fifty eight percent were macerated, 42 percent 
were fresh. Only 6.4 percent of documented stillbirths were audited of which 50.0 
percent were macerated stillbirth, 46.0 percent were fresh and 62 percent females. 
Ninety three percent had ANC attendants’ mothers with 47.7 percent booking by the 
end of second trimester. Fifty seven percent had folic acid in first trimester and 40.3 
percent completed IPT-Sulfadoxine/Pyrimethamine prophylaxis. The birth weight 
ranged 0.5 to 5.0 Kg with mean 2.8± 0.9, median 3.0 and modal weight of 3.0 Kg, sixty 
nine percent had birth weights greater ≥ 2.5Kg. Birth asphyxia caused 41 percent 
of the audited deaths and 26.9 percent unknown causes. Poor management, lack of 
expertise and inadequate human resources were identified as contributory factors 
and only 32.2 percent were monitored with partograph. CONCLUSIONS: The impor-
tance of introducing the novel stillbirth audit in the Greater Accra region cannot be 
overemphasized however, findings underscore the need to enforce implementation 
since majority (93.6 percent) of stillbirths were not audited.
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OBJECTIVES: To examine differences in the likelihood of receiving Breast Cancer 
Screening (BCS) among Medicare Advantage (MA) dual eligibles (DE) enrolled in 
Special Need Plans (D-SNPs), DE in non-SNPs (non-SNP DEs), and non-DE mem-
bers. METHODS: This study used a large nationally representative administrative 
claims database supplemented with socioeconomic and community resource data. 
The sample consisted of female MA enrollees aged 50-74 years in 2013. The outcome 
of interest was an indicator of receiving BCS based on the measure definition in 
the Healthcare Effectiveness Data and Information Set. Generalized linear mixed 
model was used to compare the likelihood of receiving BCS in the three groups 
after controlling for confounding factors (i.e., demographics, comorbidities, socio-
economic characteristics and community healthcare resources) and accounting 
for unmeasured plan characteristics as a random component. RESULTS: A total 
of 258,807 MA members were included in the study (non-DE: 76.0%, non-SNP DEs: 
10.1%, D-SNP: 13.9%). BCS rates were significantly different across all three groups 
(p-value< 0.0001). The non-DE population had higher rates (77.3%) compared to both 
non-SNP DE (72.9%) and D-SNP (76.3%). The model revealed there was no significant 
difference in the likelihood of receiving BCS between D-SNPs and non-DEs (OR: 1.1, 
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U.S. adults with end-stage renal disease. The Medical Expenditure Panel Survey, a 
representative sample of the U.S. households was utilized. End-stage renal disease 
cases with clinical classification codex value of 158 were pooled for calendar cyears 
2002 to 2011. Self-reported body mass index was classified as underweight (BMI < 
18.5), normal weight (18.50 < BMI < 24.99), overweight (25 < BMI < 29.99) and obese 
(BMI > 30). Mean annual health care use and expenditures were estimated by body 
mass index among end-stage renal disease adults. RESULTS: 1.9% of end-stager 
renal disease adults were underweight (exluded due to small sample size), 28.0% 
were normal weight, 39.0% were overweight and 31% were obese. Mean annual non-
zero hospital night stays were 25, 2, and 20 days for normal weight, overweight and 
obese end-stage renal adults. The average annual expenditures were $21672 + $4903, 
$44810 + $25906, and $71992 + 41046 among normal weight, overweight and obese 
end-stage renal disease adults. CONCLUSIONS: Obese patients had longer hospital 
stays than overweight patients and resulted in higher health care expenditures. 
End-stage renal disease patients who were obese may be more sicker. With the 
rising incidence of chronic kidney disease, overweight and obesity internationally, 
the relationship of body weight with chronic kidney disease in health care use and 
associated spending needs further exploration in larger studies.
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OBJECTIVES: Healthcare costs in the U.S. are the highest worldwide and are rapidly 
increasing. As a result of this upward trend, employers and health insurance com-
panies are trying to contain the cost of healthcare. This study aimed to understand 
and identify several factors associated with medical reimbursement amount for 
Commercial and Medicare health insurance members in Southeastern Pennsylvania 
and surrounding counties. METHODS: Using privately insured Commercial and 
Medicare health plan enrollment and claims data from 2011 and 2012 for 2 mil-
lion participants, this study empirically examined the impact of socio-demographic, 
enrollment, census data, rate relativity, utilization, risk scores and chronic diseases 
on medical reimbursement amount using risk adjustment and risk predictive models. 
The dependent variables - medical reimbursement amount, was measured separately 
as concurrent, prospective, and change variable (taking first difference) at each plan 
participant level. Regression analysis was used to examine individually and cumu-
latively how much variation was explained by different independent variables for 
Commercial and Medicare separately using adjusted R-squared. Socio-demographic 
variables included age, gender, and derived 2010 census variables at the ZIP code 
level. Separate risk scores were derived for Commercial and Medicare using DxCG’s 
all medical predicting concurrent medical risk. RESULTS: Among both Commercial 
and Medicare members, utilization (including services by inpatient, outpatient and 
professional) was the predominant predictor of medical reimbursement amount. Risk 
scores and number of chronic diseases are predictive but not as significant as utiliza-
tion in terms of explanatory power. Socio-demographic variables are important pre-
dictors but only explain a small portion of the variation. CONCLUSIONS: This study 
examined several factors associated with medical reimbursement amount. Further 
research is needed to help understand what other factors are important which may 
help shed light on potential options for ‘bending the cost curve’.
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OBJECTIVES: To describe out-of-pocket (OOP) expenditures for hospitalizations, 
ambulatory care visits and prescription medications and to determine if there is the 
difference in OOP expenditures by insurance status among subjects with Chronic 
Obstructive Pulmonary Disease (COPD). METHODS: Data for this study were drawn 
from the 2012 Medical Expenditure Panel Survey (MEPS). The sample included adults 
(≥ 18 years) with a COPD diagnosis (ICD-9 codes 491, 492, and 496) who received COPD 
services at least once in 2012. The dependent variable was annual OOP expenditures 
and the independent variable was health insurance type (private, public, or no insur-
ance). Descriptive statistics and inferential tests were conducted using SAS ProcSurvey 
for complex sampling design. RESULTS: Study subjects’ (N= 587 unweighted; 
N= 5,982,925 weighted) total mean±SE OOP COPD expenditures were $236.2±45.1 per 
person. Subjects with no insurance had total OOP expenditures ($621.3±385.9) that 
were 2.8 to 4.0 times higher than those who were privately ($221.4±22.6) or publicly 
($156.9±22.9) insured. Inpatient expenditures (N= 31 unweighted; N= 332,414 weighted) 
were significantly higher for subjects with no insurance ($4,631.7±0), and lower for 
subjects with private ($186.9±1.9) and public insurance ($105.6±4.7). Ambulatory 
care visit (N= 385 unweighted; N= 3,831,325 weighted) OOP expenditures for subjects 
with no insurance ($77.9±14.0) were over 2 times higher than OOP expenditures for 
those privately or publicly insured ($35.0±5.3; $28.2±5.6, respectively). Of those who 
had prescription expenditures (N= 468 unweighted; N= 4,906,191 weighted), patients 
with private and those with no insurance paid similar OOP amounts ($222.1±24.8; 
$224.8±61.4, respectively), while those with public insurance had lower OOP expen-
ditures ($162.5±24.4). CONCLUSIONS: When compared to subjects with private or 
public insurance, those with no insurance had higher OOP expenditures for COPD-
related total, inpatient and ambulatory care services and lower OOP expenditures 
for prescriptions. Increasing the use of appropriate COPD medications among the 
uninsured may result in cost-savings due to reduced hospitalizations.
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information regarding visual status. All-cause hospitalization was ascertained using 
Medicare claims data that were linked to MCBS. The Negative Binomial generalized 
linear model was used to quantify the relationship between VI and hospitalization 
controlling for confounding factors such as age, gender, race, income, education, 
marital status, smoking, body mass index, and chronic conditions. RESULTS: At 
baseline, 23% of beneficiaries had mild VI, and 6% had moderate-to-severe VI. Over 
time, the rate of hospitalization declined for those with mild VI or no VI, but was con-
stant for those with moderate-to-severe VI. The rate of hospitalization was higher 
in beneficiaries with moderate-to- severe VI compared with beneficiaries with no 
VI (Rate Ratio: 1.21, 95% Confidence Interval: 1.06, 1.37), adjusting for potential 
confounding variables. CONCLUSIONS: Moderate-to-severe VI was associated with 
an increased rate of hospitalization among older adults. Our results suggest that 
further research is needed to determine whether treatment of and management of 
visual impairment would be an effective measure to reduce hospitalization.
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OBJECTIVES: Depression is a major cause of increased work absentees and low pro-
ductivity increasing the total healthcare costs. Continuing to work while suffering 
from depression (presenteeism) may actually improve patient condition through col-
league support and reduce healthcare costs, however, there is not enough evidence 
to support this. The objective of this study was to compare health services utiliza-
tion and healthcare costs among employed patients with depression who engage in 
presenteeism and absenteeism. METHODS: A retrospective observational study was 
conducted using the 2011 and 2012 Medical Expenditure Panel Survey (MEPS) data. 
Adult patients (≥ 18 years) with depression were identified using ICD-9 codes (296 and 
311). All depressed patients who were employed throughout the year were assessed 
for presenteeism and absenteeism through survey responses. Logistic regressions 
were used to assess the association between absenteeism/presenteeism and office-
based visits. General linear models were used to assess the total helathcare costs 
among those who engaged in absenteeism and presenteeism. RESULTS: A total of 
1,501 adults with depression were identified. Of those, 66.7% were females. Among 
employed adults with depression, 14.7% engaged in absenteeism, while the others 
engaged in the behavior of presenteeism. After controlling for individual socio-demo-
graphic covariates, clinical comorbidities, and individual perceived health status, 
depressed patients engaging in presenteeism were 65% less likely to have more than 
three office-based visits as compared to patients engaging in absenteeism(OR: 0.349; 
95% CI: 0.235-0.518). Results for the adjusted cost analysis suggest that the behavior of 
presenteeism or absenteeism was not a significant predictor of total healthcare costs 
(p> 0.05). CONCLUSIONS: Compared to absenteeism, presenteeism among employed 
adults with depression is associated with lower health services utilization that can 
potentially be cost-saving in the long run. Employers and the medical community 
should work together for depression management among employees and reduce the 
clinical and economic burden of depression.
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OBJECTIVES: To describe and compare the first hospitalization cost and the 
readmission cost of Acute Myocardial Infarction (AMI) patients at Beijing urban 
area. METHODS: Retrospective data on hospitalization of AMI was selected from 
Beijing urban employees and residents medical insurance database. We randomly 
selected 10% of patients first diagnosed as AMI during January 2012- December 
2012and then followed those patients to September 2013 .1253 patients were 
identified in our study and then 335 patients(26.7%) reoccurred during the obser-
vation period. All information of patient demographic characters, length of stay 
and clinical costs were collected. The descriptive statistics were used. The costs 
of 2013 were converted into 2012 year price with discount rate 3.5%. RESULTS: We 
analyzed the 335 patients with recurrence of AMI,(mean age 66.14±15.04 years; 
82.39% male), among which 100 patients were readmitted to hospital over three 
times. The median followed time was 14.17(IQR11.35-18.37, mean 14.29±4.68, ) 
months. The median hospitalization cost was ¥32,148.42(IQR14303.28-68264.97, 
mean 42,905.99±36,473.35)at the first time, ¥29,189.83(IQR12111.81-64323.44, mean 
41281.34±34909.03)at the second time, and ¥25,386.72(IQR13751.55-49162.27, mean 
34859.87±30294.72) at the third time or more, respectively (p< 0.05) . The median 
length of stay was 11 days (IQR 7-16, mean 13.75±11.34days) in the first hospitali-
zation,11 days (IQR 7-16, mean 13.91±12.67,)in the second hospitalization, and 13 
days (IQR 9-19, mean 16.12±12.97days)in the third hospitalization or more ,respec-
tively. (p< 0.05) CONCLUSIONS: Patients with readmission took a relatively high 
percentage of all AMI hospitalized patients and caused heavy cost. Readmissions 
over three times had lower cost and longer length of hospital stay than the first 
and second hospitalization.
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OBJECTIVES: Chronic kidney disease, overweight and obesity are growing public 
health challenges in the U.S. with large financial implications. To examine health-
care utilization and expenditures among end-stage renal disease population by 
body mass index. METHODS: This was a retrospective cross-sectional study of 225 
